Microbial Immunotherapy
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
122
NCT05865730
A Study of Oncobax®-AK in Patients With Advanced Solid Tumors
Phase: Phase 2
Role: Lead Sponsor
Start: Oct 1, 2022
Completion: Jun 30, 2026
Loading map...